小智港股覆盤 | 10月14日
今日,港股三大指數集體上漲。截止收盤,恆生指數漲1.21%,報16587點。國企指數漲1.23%,報5629點。恆生科技指數漲1.55%,報3206點。市場約1080只個股上漲,579只個股下跌。成交額突破1019.36億港幣,和昨天同期相比增長19.94%。南下資金淨流入50.43億港幣。

盤面上,CRO板塊全線走強。粵港灣控股(舊)漲超83%;金斯瑞生物科技漲超11%;藥明康德漲超10%;維亞生物、康龍化成等多股漲超9%。藥明康德料前三季度溢利人民幣73.78億元,同比增長約107.12%;康龍化成:實控人之一樓小強質押30萬股。

醫療設備板塊暴漲。微創機器人-B漲超20%;微創醫療、愛康醫療等多股漲超13%;復銳醫療科技漲超12%;啓明醫療-B漲超11%。

生物科技板塊全線走強。康方生物-B、榮昌生物-B等多股漲超15%;科濟藥業-B、信達生物等多股漲超13%;藥明巨諾-B漲超12%。榮昌生物升7.51%錄2連陽,泰它西普獲美國孤兒藥資格認定;信達生物漲超6%,機構稱公司產品已初步形成矩陣,有望爲公司提供持續增長動力。

證券板塊走弱。阿仕特朗金融跌超19%;華融金控跌超12%;首都創投跌超11%;PF GROUP、東方匯財證券等多股跌超8%。

電力板塊走弱。中電控股、長江基建集團等多股跌超1%。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.